Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 141 followers.

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations http://t.co/naNiUSkahs

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations http://t.co/7x2HdITYCL

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations http://t.co/5TcLRXxjtV